FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+9.47%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.3B
AUM Growth
+$14.3B
(+18%)
Cap. Flow
+$1.65B
Cap. Flow
% of AUM
11.55%
Top 10 Holdings %
Top 10 Hldgs %
53.52%
Holding
113
New
19
Increased
34
Reduced
32
Closed
9
Top Buys
| 1 |
APC
Anadarko Petroleum
APC
|
$738M |
| 2 |
CELG
Celgene Corp
CELG
|
$648M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$475M |
| 4 |
RHT
Red Hat Inc
RHT
|
$339M |
| 5 |
AGN
Allergan plc
AGN
|
$167M |
Top Sells
| 1 |
TransUnion
TRU
|
$194M |
| 2 |
Meta Platforms (Facebook)
META
|
$179M |
| 3 |
Booking.com
BKNG
|
$164M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$162M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$159M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 18.98% |
| 3 | Communication Services | 14.38% |
| 4 | Industrials | 7.19% |
| 5 | Consumer Discretionary | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Voyager Therapeutics
VYGR
$206M
| $20.4M | 0.13% |
750,000
-250,158
| -25% | -$6.81M |
|
|
CCXI
77
DELISTED
ChemoCentryx, Inc.
CCXI
| $18.6M | 0.12% |
2,000,000
+500,000
| +33% | +$4.65M |
|
78
Protagonist Therapeutics
PTGX
$3.59B
| $18.2M | 0.12% |
1,500,000
-290,000
| -16% | -$3.51M |
|
|
TECX
79
Tectonic Therapeutic, Inc. Common Stock
TECX
$316M
| $16.8M | 0.11% |
1,036,147
+136,147
| +15% | +$2.21M |
|
|
NSTG
80
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.6M | 0.07% |
350,000
-50,000
| -13% | -$1.52M |
|
|
EIGR
81
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $10.6M | 0.07% |
+1,000,000
| New | +$10.6M |
|
82
Voya Financial
VOYA
$7.24B
| $10.2M | 0.07% |
185,000
| – | – |
|
83
Veracyte
VCYT
$2.39B
| $9.98M | 0.06% |
+350,000
| New | +$9.98M |
|
|
PHAS
84
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $9.93M | 0.06% |
+756,961
| New | +$9.93M |
|
85
Twist Bioscience
TWST
$1.59B
| $8.91M | 0.06% |
+307,055
| New | +$8.91M |
|
86
Savara
SVRA
$588M
| $8.24M | 0.05% |
3,475,000
+1,050,000
| +43% | +$2.49M |
|
87
uniQure
QURE
$946M
| $7.82M | 0.05% |
+100,000
| New | +$7.82M |
|
88
Milestone Pharmaceuticals
MIST
$152M
| $6.79M | 0.04% |
+250,000
| New | +$6.79M |
|
89
Cyclerion Therapeutics
CYCN
$7.78M
| $6.23M | 0.04% |
544,085
-300,000
| -36% | -$3.44M |
|
90
Personalis
PSNL
$428M
| $5.02M | 0.03% |
+184,932
| New | +$5.02M |
|
|
PFNX
91
DELISTED
Pfenex Inc.
PFNX
| $4.04M | 0.03% |
600,000
| – | – |
|
|
GCVRZ
92
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $3.55M | 0.02% |
6,827,805
| – | – |
|
93
Akero Therapeutics
AKRO
$3.6B
| $2.87M | 0.02% |
+150,000
| New | +$2.87M |
|
|
APTX
94
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.24M | 0.01% |
670,000
| – | – |
|
95
Gossamer Bio
GOSS
$582M
| $2.22M | 0.01% |
100,000
-277,852
| -74% | -$6.16M |
|
96
Larimar Therapeutics
LRMR
$328M
| $2.14M | 0.01% |
1,800,000
| – | – |
|
97
Assembly Biosciences
ASMB
$181M
| $1.35M | 0.01% |
100,000
| – | – |
|
98
Adaptive Biotechnologies
ADPT
$1.96B
| $1.21M | 0.01% |
+25,000
| New | +$1.21M |
|
99
Occidental Petroleum
OXY
$45.6B
| $1.01M | 0.01% |
+20,000
| New | +$1.01M |
|
|
GG
100
DELISTED
Goldcorp Inc
GG
| – | – |
-12,960,000
| Closed | -$148M |
|